Litigation Details for MYLAN PHARMACEUTICALS INC. v. SANOFI-AVENTIS U.S. LLC (W.D. Pa. 2023)
✉ Email this page to a colleague
MYLAN PHARMACEUTICALS INC. v. SANOFI-AVENTIS U.S. LLC (W.D. Pa. 2023)
| Docket | 2:23-cv-00836 | Date Filed | 2023-05-18 |
| Court | District Court, W.D. Pennsylvania | Date Terminated | |
| Cause | 15:2 Antitrust Litigation | Assigned To | Mark Raymond Hornak |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 9,717,852 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in MYLAN PHARMACEUTICALS INC. v. SANOFI-AVENTIS U.S. LLC
Details for MYLAN PHARMACEUTICALS INC. v. SANOFI-AVENTIS U.S. LLC (W.D. Pa. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-05-18 | External link to document | |||
| 2023-05-18 | 1 | Complaint (for Clerk of Court personnel only) | Fourth Notice Letter Patent 9,717,852 Cartridge Holder and Pen- Covenant not to … Fourth Notice Letter Patent 9,717,852 Cartridge Holder and Pen- Covenant not to …ingredient) patents, drug product (formulation and composition) patents, and method of use patents.” Abbreviated…1997, the Patent and Trademark Office (“PTO”) issued U.S. Patent No. 5,656,722 (“the ’722 patent”) for insulin…polysorbate vial formulation patents, Sanofi listed the ’652 patent and the ’930 patent to be identified in the | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
